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The evolution of Bordetella pertussis from a common ancestor similar to Bordetella bronchiseptica has 
occurred through large-scale gene loss, inactivation and rearrangements, largely driven by the spread 
of insertion sequence element repeats throughout the genome. B. pertussis is widely considered to 
be monomorphic, and recent evolution of the B. pertussis genome appears to, at least in part, be 
driven by vaccine-based selection. Given the recent global resurgence of whooping cough despite the 
wide-spread use of vaccination, a more thorough understanding of B. pertussis genomics could be 
highly informative.  In this chapter we discuss the evolution of B. pertussis, including how vaccination 
is changing the circulating B. pertussis population at the gene-level, and how new sequencing 
technologies are revealing previously unknown levels of inter- and intra-strain variation at the 
genome-level.  
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1. The ongoing problem of Bordetella pertussis 
Whooping cough, the infectious respiratory disease caused by the bacterium Bordetella pertussis, has 
been resurgent in many countries for the past two decades. This resurgence comes in spite of a global 
vaccination programme, with 90% of the target population receiving a single dose of pertussis-
containing vaccine, and 85% receiving three doses (WHO 2018). In addition, there has been a shift in 
the epidemiological profile of the disease: whereas once most cases were reported in infants and 
unvaccinated children, the resurgence is also affecting vaccinated children, adolescents and adults, 
Figure 1 (Strebel et al. 2001; Clark 2014). Data from the Centers for Disease Control, for example, show 
Figure 1: Reported incidence of whooping cough per 100,000 in the USA, 1990-2017, showing increase in all age brackets. 
Data source: CDC National notifiable diseases surveillance reports (Centers for Disease Control 2019) 
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that from 1990-1997, the mean incidence of whooping cough per year in 11-19 year-olds was 2.54 per 
100,000 people, whereas from 2010-2017, it was 20.43 (Centers for Disease Control 2019). 
The original vaccination programme, introduced in the 1940s and 1950s, used a whole-cell vaccine 
(WCV). Initially, cases of the disease appeared to drop significantly. Due to perceived reactogenicity 
of the WCV (now largely discredited), it was replaced in many countries throughout the 1990s and 
early 2000s with an acellular vaccine (ACV) (for example: Cherry 1990, 1992, 1996; Cherry et al. 1993; 
Blumberg et al. 1993; Moore et al. 2004). The acellular vaccine contains one to five B. pertussis 
antigens, including Pertussis toxin (ptx), pertactin (prn), filamentous haemagglutinin (FHA) and the 
fimbrial proteins Fim2 and Fim3. These days, most developed countries use the ACV, although many 
developing countries continue to use the WCV. The recent use of the ACV has been strongly implicated 
in whooping cough’s resurgence. However, concerns were raised about waning immunity conveyed 
by the WCV beginning in the early 1990s and, in many countries, the resurgence does seem to pre-
date the switch to the ACV (De Serres et al. 1995; Cherry 1996; de Melker et al. 1997).  
Three main potential causes are thought to have contributed to the recent observed increase in 
whooping cough cases: increased awareness of the disease coupled with improved diagnosis due to a 
switch from culture-based to PCR- and serology-based techniques; waning immunity, particularly that 
conveyed by the ACV compared to the WCV; and genetic variations in circulating B. pertussis strains, 
away from the vaccine strains (Sealey et al. 2015; Clark 2014; Ausiello and Cassone 2014). Here we 
focus on the latter from two different but highly interrelated perspectives: variation at the gene-level, 
and variation at the genome-level, with particular consideration of how recent developments in 
genomic research have contributed to our understanding of evolution and variation in a species which 





2. The speciation of Bordetella pertussis 
The study of the bordetellae has focussed largely on the three classical, pathogenic, Bordetella species: 
B. bronchiseptica, B. pertussis and B. parapertussis. However, the Bordetella genus contains many 
additional species which have been isolated from extremely diverse environments, including marine 
sponges, bioreactors, nitrifying sludge and mural paintings in ancient tombs (Wang et al. 2007; Bianchi 
et al. 2005; Sun et al. 2019; Tazato et al. 2015). Using previously published 16S sequence data derived 
from many Bordetella species to create a phylogenetic tree, Hamidou Soumana et al. (2017) 
demonstrated that eight out of the ten clades contained soil-dwelling bordetellae; the permeation of 
the environmental phenotype throughout the phylogenetic tree hints at a soil-based origin for the 
Bordetella genus.  
Key evolutionary milestones within the genus involve species that are capable of both environmental 
and pathogenic lifestyles, such as the key ancestor to the classical Bordetella species, a B. 
bronchiseptica-like bacterium. Multilocus sequence typing (MLST) studies of B. bronchiseptica have 
established two distinct complexes of isolates, complex I and IV. The majority of strains isolated from 
humans originate from Complex IV (Diavatopoulos et al. 2005; Park et al. 2012). Using the much higher 
discriminatory power of next generation sequencing (NGS) data, it has been demonstrated that B. 
pertussis and B. parapertussis evolved from different complexes, with B. parapertussis sharing a more 
recent ancestor with Complex I and B. pertussis with Complex IV (Linz et al. 2016).  
Table 1: Characteristics of all classical Bordetella closed genomes available on RefSeq, March 2019 
Characteristic B. pertussis B. parapertussis B. bronchiseptica 
Number of closed genomes 421 18 19 
Genome size / Mb 1 4.11 (4.04 – 4.39) 4.78 (4.77 – 4.90) 5.21 (5.08 – 5.34) 
Number of predicted genes 1 3,979 (3,856 – 4,239) 4,501 (4,490 – 4,574) 4,911 (4,774 – 5,090) 
Number of proteins 1 3,615 (3,425 – 3,866) 4,166 (4,157 – 4,184) 4,804 (4,663 – 4,993) 
G+C % 1 67.7 (67.7 – 67.8) 68.1 (67.8 – 68.1) 68.2 (68.1-68.4) 
IS 481 1 256 (234 - 273) - 1 (0-3) 
IS 1001 1 - 22 (22-28) 1 (0-1) 
IS 1002 1 8 (5 – 10) 9 (0-9) 0 (0-5) 
IS 1663 1 17 (16 – 24) - 2 (0-14) 
1 Figures shown are mean and (range) 
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Despite their apparently different evolutionary trajectories, B. pertussis and B. parapertussis cause 
remarkably similar pathologies in humans. In an example of convergent evolution, the genomes of 
both species have evolved primarily through genome reduction, mediated through homologous 
recombination of insertion sequences (IS). As seen in table 1, the genome of B. bronchiseptica contains 
very few IS elements; in fact, the reference strain RB50 was originally believed to contain no IS 
elements at all (Parkhill et al. 2003; Preston et al. 2004). In contrast, B. parapertussis genomes contain 
around 30 IS elements, usually 22 copies of IS 1001 and 9 copies of IS 1002. The B. pertussis genome 
contains the most IS elements:  up to ten copies of IS 1002, around 20 copies of IS 1663, and over 200 
copies of IS 481. The appearance and expansion of these IS elements is thought to have led to the 
speciation of B. pertussis and, separately, B. parapertussis, from their B. bronchiseptica-like ancestors 
(Parkhill et al. 2003; Preston et al. 2004; Diavatopoulos et al. 2005). 
Genome reduction was key in the speciation of B. pertussis. The significant, IS-mediated, reduction in 
genome size of the B. pertussis genome (around 4.1 Mb) compared to the B. bronchiseptica genome 
(around 5.3 Mb) has led to a streamlined genome, depleted of many metabolic, membrane transport, 
surface structure synthesis and gene expression regulatory genes when compared to B. bronchiseptica 
genomes (Parkhill et al. 2003). Comparative genomic studies between B. bronchiseptica and B. 
pertussis reveal that the latter has around 1200 fewer genes (Parkhill et al. 2003; Linz et al. 2016). In 
addition, insertions of IS elements into genes which are functional in B. bronchiseptica has resulted in 
the existence of over 350 pseudogenes in B. pertussis, compared to only around 20 in B. 
bronchiseptica. This sculpting of the B. pertussis genome via IS-mediated homologous recombination 
has produced a highly specialised pathogenic bacterium which is niche-restricted to the human 
nasopharynx. Traditionally, B. pertussis has been described as a monomorphic species (for example: 
Mooi 2010; Bart et al. 2010); however, since the advent of whole genome sequencing, genomics has 
been revealing that the bacterium may be less clonal than previously thought, with the introduction 
of vaccination and continued homologous recombination between IS elements driving gene- and 
genome-level variations respectively. 
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3. Vaccination has accelerated B. pertussis gene-level evolution 
3.1 Changes to circulating alleles 
Over the last several decades, allele-typing of selected genes has shown a number of similar trends, 
characterised largely by the drift of genes away from the vaccine alleles (for example: Mooi et al. 1998; 
van der Zee et al. 1996; Mooi et al. 2001). One well-reviewed example involves pertussis toxin. Prior 
to the 1990s, the predominant ptx promoter allele was ptxP1. A new allele, ptxP3, was first observed 
in 1988 (Bart et al. 2010). In ptxP3, a SNP in the binding site for ptx’s transcriptional regulator, BvgA, 
appears to increase the binding affinity between the promotor and regulator, thus increasing 
transcription and causing ptxP3-carrying strains to produce more ptx. The expression of other proteins 
involved in complement resistance is also altered and, together, these changes increase the 
transmissibility and severity of the disease caused by ptxP3-carrying strains (Mooi et al. 2009; Bart et 
al. 2010; King et al. 2013; de Gouw et al. 2014).  This new allele spread rapidly throughout the 1990s, 
and ptxP3 is now present in greater than 90% of recent isolates (Lam et al. 2012; Bart et al. 2010). A 
thorough screen of 343 strains representing 19 countries and six continents, spanning 90 years of B. 
pertussis isolation, showed that similarly rapid selective sweeps have also occurred in other antigen-
related genes, including ptxA, prn, and fim3 (Bart et al. 2014a) . 
In addition, analysis of 100 strains isolated during a 2012 whooping cough outbreak in the UK, after 
the introduction of the ACV, showed that the evolution of the antigens included in the ACV is occurring 
more rapidly than that of the surface proteins not included in the ACV (Sealey et al. 2015). Importantly, 
this analysis also showed that numerous different strains were circulating during the outbreak, rather 
than one particularly virulent strain or allelic profile being responsible. The same was also true for 
strains circulating during outbreaks in the USA, in California in 2010, and in Vermont and Washington 
in 2012 (Bowden et al. 2014; Bowden et al. 2016).  This suggests that the strains circulating during 
outbreaks tend to be the same as those that circulate during non-outbreak periods, but that some 
unknown trigger causes an increase in whooping cough cases in regular four-yearly cycles.  
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Supporting the idea that the recent allelic changes we are seeing in B. pertussis are, in part, a response 
to the introduction of vaccination, Xu et al. (2015) and Du et al. (2016) showed that, in countries where 
vaccine uptake has been lower or delayed, the rate of change to the allelic profile of circulating strains 
has also been delayed. In the Philippines, for example, where the WCV is still in use, prn2 has yet to 
appear, despite being the allele most frequently seen in ACV-adopting countries (Galit et al. 2015).  
3.2 The proliferation of antigen-deficient strains 
Another gene-level phenomenon which has been observed recently is the emergence of strains 
deficient in one or more of the antigens used in the ACV. During the pre-ACV era, antigen-deficient 
strains were occasionally isolated, albeit at very low frequencies. Individual strains with mutations 
(deletion, frameshift, and premature stop codons) which resulted in the non-expression of pertactin 
were, for example, isolated in Europe, North America and Japan in the 1990s (Mastrantonio et al. 
1999; Weigand et al. 2018; Miyaji et al. 2013). The landmark study by Bart et al. (2014a), in which all 
but around 20 strains were isolated prior to 2007, did not identify any strains which were prn-deficient 
(although one, BP310, has subsequently been resequenced by Zomer et al. (2018) and is likely to be 
deficient). Since the mid-2000s, however, the number of prn-deficient strains being isolated globally 
has increased rapidly. A study of Australian isolates from 2008-2012 showed an increase from 5% prn-
deficient strains in 2008 to 78% prn-deficient strains in 2012 (Lam et al. 2014). Pertactin-deficiency 
appears to be polyclonal, affecting both dominant prn alleles, prn1 and prn2, and arising through 
several different mechanisms including insertions of IS 481, large deletions, and SNPs, with no single 
predominant causative mutation (Hegerle et al. 2012; Queenan et al. 2013; Barkoff et al. 2019).  
As with changes to allelic profiles, countries with different vaccination strategies appear to be 
differently affected by the proliferation of antigen-deficiency. A longitudinal study of prn-deficiency 
in European countries between 1998 and 2015, figure 2, showed that the number of prn-deficient 
strains is increasing in all screened countries but, the earlier a country introduced the ACV, the higher 
the percentage of strains currently found to be deficient (Barkoff et al. 2019). The rapid recent 
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increase in prn-deficiency suggests that, although the deficiency may have always occurred in some 
strains by chance, it has been strongly selected for by the ACV compared to the WCV. Further 
supporting the idea of ACV-mediated selection pressure is the sustained decrease of prn-deficient 
strains circulating in Japan since pertactin was removed from the Japanese ACV in 2012 (Hiramatsu et 
al. 2017).  
A smaller number of strains deficient in other antigens included in the ACV have also been identified.   
Bart et al. (2015) and Weigand et al. (2018) identified several geographically independent recent 
strains which were unable to produce FHA; the same strains were often also prn-deficient. In addition, 
a handful of strains have been isolated globally which are deficient in both prn and ptx (Bouchez et al. 
2009; Williams et al. 2016; Weigand et al. 2018). However, both FHA and Pertussis toxin are thought 
to play more vital roles in whooping cough disease development than pertactin (Carbonetti 2010; 
Henderson et al. 2012; Serra et al. 2011). Hence, although occasional strains may develop deficiency 
in these antigens, the reduced ability of these deficient strains to survive in the host and cause disease  
Figure 2: Correlation between the introduction of a primary acellular pertussis vaccine containing pertactin (PRN) in a 
European country and the proportion of PRN-deficient isolates found in the study, 2012–2015. Reproduced with 
permission from Barkoff et al. (2019) 
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and may mean that this kind of antigen deficiency is unlikely to proliferate in the same way as prn-
deficiency.  
4.  Recent sequencing advances highlight genome-level variation 
4.1 The limitations of short-read sequencing 
Whilst the wide availability of whole genome sequencing throughout the 2000s enabled a variety of 
high-throughput strain screens, the highly repetitive nature of the B. pertussis genome has made the 
assembly of single-contig B. pertussis genome sequences difficult. Genome sequencing requires an 
organism’s genome to be sheared into smaller fragments prior to sequencing; one of the goals of 
genomics is to fully re-assemble these fragments back into their original order. The goal when 
sequencing an organism with a single chromosome, like B. pertussis, would therefore be to re-
assemble the sequenced fragments into a single, closed genome sequence. IS 481, however, together 
with the smaller number of copies of other repeated regions, such as IS 1002, IS 1663 and the rRNA 
operon, has confounded attempts to assemble closed B. pertussis genomes using short-read 
sequencing technologies, which sequence fragments shorter than the repeated section. The hundreds 
of B. pertussis genomes assembled using short-read sequencing alone have tended to consist of 
several hundred fragments, or “contigs”: ostensibly one per repeat in the genome. Thus, the majority 
of high-throughput screens throughout the 2000s were focussed on the gene-level differences 
between strains already discussed, rather than comparisons on a whole genome-level. 
The presence of so many IS elements, however, means that assembly of closed B. pertussis genomes 
could be particularly informative: IS elements are able to move around the genome through 
homologous recombination, potentially causing genome-level structural changes which may be 
discernible only through single-contig assemblies (Bentley et al. 2008; Siguier et al. 2014). Despite the 
discovery that most whooping cough outbreaks tend to be polyclonal in nature, B. pertussis remains 
a relatively clonal species, with a low SNP rate compared to many other bacteria. In other species, in 
addition to gene-level variations, differences at a whole-genome level are known to contribute to 
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altered gene expression and phenotypic diversity (Darch et al. 2014; Sousa et al. 1997). IS-mediated 
rearrangement may affect gene regulation and/or expression in B. pertussis by a number of 
mechanisms, including IS 481’s inwards and outwards-facing promoters, as well as changing the 
distance of genes from the origin of replication (Amman et al. 2018). Limited evidence has already 
shown that certain genome-level differences can affect phenotype in B. pertussis in this way  (Brinig 
et al. 2006).  
The speciation of B. pertussis from B. bronchiseptica via IS element-mediated homologous 
recombination resulted in a variety of genomic arrangement differences between the two species 
alongside the reduction in genome size, and it is likely that IS-mediated genomic rearrangement in B. 
pertussis is an ongoing process (Parkhill et al. 2003). Indeed, prior to the advent of long-read 
sequencing, pulsed-field gel electrophoresis (PFGE) was one of the few methods able to discriminate 
between highly clonal B. pertussis strains: isolate screens using PFGE indicated that strains which 
seemed otherwise alike could vary significantly in terms of PFGE type (van Gent et al. 2015; Bisgard et 
al. 2001; Advani et al. 2004; Advani et al. 2013). Although the existence of numerous PFGE types was 
widely seen, however, it could not be confirmed how different PFGE types arose; they could represent 
different genomic arrangements, but could also have arisen due to mutagenesis at PFGE restriction 
sites, for example.  
Thus, closed B. pertussis genome sequences may validate and further reveal genome-level differences 
between strains which otherwise appear to have highly similar or identical DNA content. The recent 
availability of long-read sequencing techniques, which can produce sequencing reads longer than 
1,000 bp, has therefore revolutionised our ability to discover and investigate genome-level variations 
in B. pertussis.   
4.2 Long-read sequencing shows extensive inter-strain genome rearrangement 
The first study to take advantage of long reads utilised Pacific Biosciences (PacBio) sequencing to 
produce closed, fully annotated, genomes for two B. pertussis strains: BP1917 and BP1920 (Bart et al. 
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2014b). The arrangement of these two strains differed significantly, with three large inversions and a 
variety of deletion and/or insertion events between the pair, figure 3. Having proven the ability of 
long reads to close the genomes of BP1917 and BP1920, Bart et al. (2015) next sequenced 11 B. 
pertussis strains which represented the pandemic ptxP3 lineage, again using PacBio sequencing to 
produce 10 kb-long reads. This cohort, which also included several strains deficient in prn and/or FHA, 
were characteristically similar in terms of SNPs but again showed significant differences in genome 
arrangement. As is common for a developing technology, the cost of PacBio sequencing has rapidly 
decreased. Thus, higher-throughput strain screens have become increasingly feasible. Figure 4 shows 
the dramatic increase in closed genome sequences for the classical Bordetella species available from 
the NCBI’s RefSeq database since 2014. Bowden et al. (2016) conducted the first whooping cough 
outbreak screen using long-read sequencing alongside short-read sequencing in hybrid, sequencing 
31 strains which had circulated during US whooping cough outbreaks in 2010 and 2012. The hybrid 
approach has been shown to improve the accuracy of assemblies produced using long-read 
sequencing, which still have an intrinsically higher error rate than short-read-only assemblies, 
particularly in homopolymeric tracts (Au et al. 2012; Koren et al. 2012). In the 31 genomes studied, 21 
different arrangement profiles were observed; most consisted of inversions around the origin of 
replication. Bowden et al. also validated the arrangements using whole genome optical mapping and 
found that, in all cases, the boundaries between rearranged sections were composed of a repeated 
element: an insertion sequence, or the rRNA operon. The vast majority of the boundaries were IS 481 
Figure 3: Different arrangements of the B. pertussis genome seen in BP1917 and BP1920. Three large sections of the genome 
(1, 2, and 3) are inverted in BP1920, as shown by their appearance on the complementary strand when the two whole 
genome sequences are aligned using progressiveMauve (Darling et al. 2010). The Genbank accession numbers for the 
genome sequences produced by Bart et al. (2014b) for BP1917 and BP1920 are CP009751 and CP009752, respectively.   
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(89%), whilst the rest were composed of an rRNA operon, IS 1002 or a combination of IS 1002 and IS 
481 together. 
The most thorough investigation of B. pertussis genomic rearrangement to date also used a hybrid 
assembly strategy, combining PacBio long reads with Illumina short reads to close the genomes of 257 
strains, dating from 1939 to 2014 (Weigand et al. 2017). When clustered based on their arrangement 
profiles, most isolates clustered according to allelic profile; for example, most ptxP1 strains shared 
similar arrangements with other ptxP1 strains. This clustering indicates that most structures are 
relatively stable, as supported by a clinical isolate which showed the same structure before and after 
11 serial passages. Furthermore, these findings suggest that lineages are conserved not just in terms 
of SNPs, but also in genomic arrangement. Interestingly, Weigand et al. note that, on average, only 
half of their predicted IS 481 target sites are occupied in any given genome, suggesting a potential for 
further IS-mediated structural changes in future generations, assuming these sites are not non-
permissive. 
Figure 4: Increase in numbers of closed classical Bordetellae genome sequences (available on RefSeq) since the commercial 
introduction of long-read sequencing technologies 
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5. How else might B. pertussis generate diversity through genome-level 
variation? 
The primary metric commonly used to assess diversity of bacterial species is SNPs. However, B. 
pertussis is a textbook example of a clonal bacterial pathogen: variation, when judged by SNPs alone, 
is extremely limited, even taking into account the accelerated mutation of B. pertussis genes since the 
introduction of vaccination. Bart et al. (2010) estimated the mutation rate between B. pertussis 
isolates to be 1 SNP per 8,675 bases, compared to, for example, 1 SNP per 3,000 bases in 
Mycobacterium tuberculosis, and 1 SNP per 6,700 bases in Escherichia coli O157:H7 (Fleischmann et 
al. 2002; Gutacker et al. 2002; Zhang et al. 2006). Diversity within a species is vital for its survival, in 
order to drive adaptation; this is particularly true for pathogens, which are under pressure from the 
immune system (Mooi 2010). Therefore, a prominent question in B. pertussis genomics is: despite 
limited SNP diversity, how does B. pertussis generate diversity? The large numbers of closed genomes 
assembled using long-read sequencing have proven that rearrangements are a rich source of genome-
level diversity, but can genomics also reveal other types of genome-level variation?  
5.1 Harnessing deletion as a driver of diversity 
King et al. (2010) analysed the size of B. pertussis genomes of strains isolated over a 60-year period, 
demonstrating that genome streamlining has been an ongoing process, with recently isolated strains 
having smaller genomes and higher numbers of pseudogenes. Thus, B. pertussis is described as a 
species which is still undergoing genome reduction. Like genomic rearrangement, reduction is driven 
primarily by homologous recombination between insertion sequences. The large numbers of 
homologous IS elements in B. pertussis therefore produce a fertile mutational landscape capable of 
the generation of diversity.   
Many bacterial species also generate diversity through the gain of genes, often by horizontal gene 
transfer (HGT), resulting in fluid gene content of the population, enabling the population to effectively 
respond to evolutionary bottlenecks that may arise over long or short timescales. In B. pertussis, 
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however, HGT appears to occur very rarely (Linz et al. 2016). Gene content of a species or genus is 
often analysed using a “pangenome” approach, which consists of analysing which genes are 
consistently present (the core genome) in the population, and which genes are variably present (the 
accessory genome) (reviewed in Medini et al. 2005; Rouli et al. 2015). A number of studies have 
undertaken this analysis in B. pertussis using either comparative genomic hybridization (CGH) (for 
example: Zhang et al. 2006; Caro et al. 2006; Heikkinen et al. 2007; King et al. 2008) or NGS (for 
example: Park et al. 2012; Ding et al. 2017). These have shown that, despite extremely limited HGT 
and otherwise high levels of clonality between strains, B. pertussis maintains a moderate accessory 
genome, largely through gene loss rather than gene gain. For example, the most comprehensive 
pangenome study to date, using CGH on 171 B. pertussis strains, revealed that 15% of the genes 
present in the population appeared variably in the 171 strains studied.  (King et al. 2010). By using a 
set of probes which included B. bronchiseptica and B. parapertussis, King et al. were able to avoid 
biasing their analysis towards genes that were present only in the B. pertussis reference strain, 
Tohama I, which has been shown to lack over 45 kb of the accessory genome of the population (Caro 
et al. 2008; Bouchez et al. 2008).  
There is a lack of knowledge about the phenotypic impact of gene deletions in B. pertussis, however. 
As the cost of sequencing has plummeted, the frequency and ease with which genomes, and their 
constituent mutations, are published has far outpaced the publishing of their phenotypic impact. To 
cope with the deluge of data, ontology schemes strive to categorize genes into functional groups and 
estimate their function based on sequence homology. A variety of nucleotide polymorphisms in B. 
pertussis, such as those in ptxP3, have had their phenotypic impacts analysed, with some providing 
clear fitness advantages in the mouse model (Mooi et al. 2009). In contrast, many key gene deletions 
have yet to be experimentally characterized in B. pertussis. Using the ontology scheme Clusters of 
Orthologous Genes (COG), King et al. (2010) showed that, as expected, housekeeping genes were 
underrepresented in the deleted genes, whilst genes of unknown function were overrepresented by 
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25%. There therefore remains genetic “dark matter”, genes with unknown function which are 
overrepresented in gene deletions. 
Whilst B. pertussis is undisputedly undergoing genome reduction, evolution acts on phenotypes rather 
than genotypes. Therefore, it is likely that the B. pertussis genome is undergoing streamlining as an 
effect of certain phenotypes being selected against. It has been theorised that the transcriptional and 
translational cost of superfluous genes far outstrips the mere cost of DNA replication of such regions 
(Adler et al. 2014). B. pertussis maintains many seemingly functionless pseudogenes, despite the vast 
majority being shown to be transcriptionally inactive in vitro and in the mouse model (Bart et al. 2010; 
King et al. 2008; de Gouw et al. 2014). This supports the idea that the deletion of some genes provides 
a greater fitness benefit than the deletion of some others. Nonetheless, there is also evidence that 
the DNA content of the species is under selection, as pseudogenes have been shown to be mildly 
enriched in gene deletions, suggesting that streamlining of the DNA is also favoured to some extent 
(Kuo and Ochman 2010). Thus, the process of B. pertussis genome streamlining is likely to be a balance 
between entirely passive and entirely directed. 
There have been five deleted regions, totalling over 50 genes, that have been deleted in all recently 
isolated clinical strains in comparison to the reference strain Tohama I (King et al. 2010; Heikkinen et 
al. 2007; Bouchez et al. 2008). In addition to clinical strains, Bart et al (2014a) also investigated two 
strains that were used to make WCVs. In one of the vaccine strains, the five deleted regions were 
present; if these regions impact cell surface antigens, the immunity conveyed by the WCV could 
therefore also be affected. This highlights the clinical importance of understanding the continual 
evolution of B. pertussis, which is in part driven by genome reduction. 
5.2 Harnessing duplication as a driver of diversity 
Homologous recombination between IS elements has not only caused rearrangements and deletions 
in the B. pertussis genome, but also duplications ranging from single genes to large, multi-gene, 
regions. The general paradigm under which duplications occur is that a gene is duplicated, thus freeing 
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the second copy from the purifying selection of the original copy of the gene, potentially allowing it 
over time to evolve a new function. However, the second copy of the gene may also maintain the 
same function of the first gene. These types of events are “canonical” duplications that are well 
documented in the bacterial kingdom (for example: Ohta 1989; Lynch 2002; Magadum et al. 2013). 
Taking the genes from Tohama I and clustering them based on 90% nucleotide homology using the 
tool CDHIT (available as a web server: http://weizhong-lab.ucsd.edu/cdhit_suite/cgi-
bin/index.cgi?cmd=cd-hit-est), it can be seen that Tohama I maintains two copies of nine separate 
genes ranging from 97% to 100% homology (excluding IS elements and rRNA genes) The maintenance 
of these duplications provides further evidence that it is not the genome size of the bacterium itself 
that is the primary target of streamlining but certain phenotypic traits which are coded in the DNA. 
Before the cost of NGS rapidly decreased in the late 2000s and early 2010s, duplications were primarily 
inferred by increased spot intensity in CGH or disturbances to southern blotting or PFGE patterns. 
Using these techniques, a number of multi-gene duplications were serendipitously discovered in the 
B. pertussis population. Using the power of long-read sequencing technologies, a number of studies 
had revealed further duplications, bringing the total to 13 serendipitously discovered mutations (Dalet 
et al. 2004; Caro et al. 2006; Heikkinen et al. 2007; Weigand et al. 2016; Dienstbier et al. 2018; Ring et 
al. 2018; Weigand et al. 2018).  A recent study by Abrahams et al. (In preparation) systematically 
analysed the B. pertussis population in search of large multi-gene duplications. Previously published 
short-read sequencing data were utilised and read depth abnormalities were used to predict 
duplications. In the 473 strains analysed, over 400 duplications were found.  
Abrahams et al. (In preparation) presents a deep description of duplications in B. pertussis. In addition 
to the quantity of duplications, over 90% of duplications were found at 11 “hotspot” loci but with 
varying gene contents, similar to a situation described previously in M. tuberculosis (Weiner et al. 
2012). Interestingly, when the CNVs at each hotspot loci were mapped to a phylogenetic tree based 
on core genome SNPs, they appeared not to be vertically inherited and instead appeared to occur 
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spontaneously many times at similar loci with subtly different gene content in each mutation, 
suggesting the existence of a potential phenotypic driver at those loci. 
Large multi-gene duplications are known to be unstable in the bacterial kingdom, and this has also 
been demonstrated in B. pertussis. For instance, Dalet et al. (2004) noticed that subculturing a single 
isolate produced both high haemolytic and average haemolytic single colonies. Further analysis 
showed that colonies with high haemolysis had a duplication of the locus encoding adenylate cyclase, 
a key virulence factor. Dalet et al. further demonstrated that subculturing a strain with a duplication 
produced colonies with a single copy of the locus, thus indicating a mixed population, ostensibly 
caused by an unstable locus. This early study used PFGE and southern blotting to screen colonies for 
copy number of the locus. These “pre-genomics” tools provide high quality data, but largely answer 
very specific research hypotheses, in contrast to sequencing experiments, which shed light on a vast 
range of research questions. Abrahams et al. used ultra-long nanopore sequencing reads (over 3,000 
reads longer than 50 kb) to confirm the presence of between 1 and 5 copies of a single locus within 
an otherwise clonal population. This tentatively supports the findings of Dalet et al., showing that in a 
single sample there exists a variety of genetic configurations of a single locus. This study demonstrates 
the potential of long-read sequencing to not only confirm long-predicted genomic structural variations 
in B. pertussis, but also to play a key role in the discovery and further investigation of a variety of 
entirely unpredicted genomic phenomena. The next steps in understanding these new genomic 
phenomena in B. pertussis should aim to elucidate the existence and extent of any phenotypic effects 
stemming from large duplicated regions, as well as any contribution they make to whooping cough 
virulence. 
6. What is the future for B. pertussis genomic research? 
Changes to the allelic profile of circulating B. pertussis strains have been recorded for many decades, 
in the pre-genomics era and beyond. The wide-spread availability of whole genome sequencing since 
the early 2000s, though, has enabled the screening of larger numbers of strains isolated over the last 
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hundred years, thus allowing us to understand, longitudinally, the extent to which B. pertussis has 
been evolving on the gene-level.  As seen above, there is evidence that many of these gene-level 
changes, in terms of both allelic profile and antigenic deficiency, have been influenced by the 
introduction of first the WCV and then the ACV. Since the 2010s, long-read sequencing has allowed us 
to investigate B. pertussis on a new level, that of the whole genome. The existence of a wide variety 
of inter-strain genomic rearrangements is now well-established, and more recent evidence has begun 
to show that other types of genome-level differences, such as large tandem duplications, also exist. 
However, the contribution of these observed gene- and genome-level variations to observed 
phenotypes is yet to be fully understood. In addition to informing our understanding of the continued 
evolution of the B. pertussis genome, a more thorough understanding of B. pertussis genomics could 
also contribute significantly to the future of whooping cough prevention strategies (Cherry 2019). 
Long-read sequencing will have a major part to play in any future investigation of B. pertussis genomic 
variations. Until recently, high-throughput long-read sequencing was restricted to larger laboratories 
which could afford a PacBio sequencing system, thus all the early long-read studies described here 
took place at national health laboratories: the CDC in the US, and the Centre for Infectious Diseases 
Control in the Netherlands. Oxford Nanopore Technologies (ONT) sequencing may provide a more 
accessible alternative for smaller laboratories and, indeed, two studies from late 2018 have shown the 
feasibility of assembling multiple closed B. pertussis genomes using ONT sequencing in hybrid with 
Illumina sequencing (Ring et al. 2018; Bouchez et al. 2018). In addition, ultra-long ONT sequencing has 
recently revealed yet further B. pertussis structural complexity, in the form of highly mixed 
populations (Abrahams et al. In preparation). Thus, it is likely that future studies of B. pertussis genome 
structure will utilise both PacBio and ONT sequencing. For investigating the most complicated 
structural features, such as very long tandem duplications, there will likely be a preference for ONT 
sequencing, as there is theoretically no upper limit to the length of sequencing read which could be 
produced by nanopore sequencing (Schmid et al. 2018). It is also likely that any studies utilising long 
reads to investigate B. pertussis  will use them in hybrid with a more accurate short-read technology, 
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although improvements to both long-read technologies mean that highly accurate long-read-only 
assemblies are on the horizon, which could enable both base-level and genome-level interrogations 
using a single technology (Wenger et al. 2019; Oxford Nanopore Technologies 2018).  
Alongside sequencing, there will still remain a place for other genomics tools, such as PFGE and optical 
mapping. The most recent survey of B. pertussis genomic diversity in the US, by Weigand et al. (2019), 
demonstrates the potential for such a wholistic approach. Using a combination of short-read 
sequencing, long-read sequencing, multilocus variable-number tandem-repeat analysis (MLVA), PFGE 
and optical mapping, Weigand et al. were able in a single study to characterise the gene- and genome-
level profiles, including allelic-profile, antigen deficiency, genome arrangement and the existence of 
several large tandem duplications, in 170 strains isolated between 2000 and 2013. Such detailed 
analyses will likely provide a springboard for future studies, for both the continued surveillance of B. 
pertussis evolution, and the investigation of any correlation between genotypic, genomic and 
phenotypic differences. 
7. Concluding remarks 
In summary, genomics has shown, and continues to show, that B. pertussis is not necessarily the 
entirely monomorphic species it is traditionally believed to be. Although the allelic profile of B. 
pertussis changed in response to the introduction of the WCV, and more rapidly since the switch to 
the ACV, diversity at the gene-level remains very limited when compared to many other bacteria. 
However, the wide availability of WGS, and particularly the more recent long-read sequencing 
technologies, have revealed dynamic and substantial genome-level variations, both between and 
within strains. Future work may utilise a wholistic approach, focussing on the further elucidation and 
phenotypic characterisation of both gene- and genome-level phenomena together, ultimately 
informing our understanding of how diversity is generated in species with limited base-level inter-




Figure 1: Reported incidence of whooping cough per 100,000 in the USA, 1990-2017, showing increase 
in all age brackets. Data source: CDC National notifiable diseases surveillance reports Centers for 
Disease Control (2019) 
Figure 2: Correlation between the introduction of a primary acellular pertussis vaccine containing 
pertactin (PRN) in a European country and the proportion of PRN-deficient isolates found in the study, 
2012–2015. Reproduced with permission from Barkoff et al. (2019) 
Figure 3: Different arrangements of  the B. pertussis genome seen in BP1917 and BP1920. Three large 
sections of the genome (1, 2, and 3) are inverted in BP1920, as shown by their appearance on the 
complementary strand when the two whole genome sequences are aligned using progressiveMauve 
(Darling et al. 2010). The Genbank accession numbers for BP1917 and BP1920 are CP009751 and 
CP009752, respectively.   
Figure 4: Increase in numbers of closed classical Bordetellae genome sequences (available on RefSeq) 
since the commercial introduction of long-read sequencing technologies 
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